Illumina

Illumina builds next-generation DNA sequencing systems, reagents/consumables, and bioinformatics software used by research, clinical, pharmaceutical, and agricultural genomics labs. Its business model combines sale of instruments with recurring consumables, sequencing services, and cloud analysis tools; the company was founded in 1998, is headquartered in San Diego, and trades on NASDAQ under the ticker ILMN.